Trial Tests Atezolizumab Plus Capecitabine in Triple-Negative Breast Cancer
A groundbreaking randomized phase II clinical trial, designated the MIRINAE trial (KCSG-BR18-21), has recently emerged from South Korea investigating innovative ...
A groundbreaking randomized phase II clinical trial, designated the MIRINAE trial (KCSG-BR18-21), has recently emerged from South Korea investigating innovative ...
The landscape of anal squamous cell carcinoma (ASCC), a rare yet increasingly prevalent malignancy, is undergoing a profound transformation fueled ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine